LS Investment Advisors’s GSK GSK Stock Holding History

LS Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,000	Closed	-$50K	–	1767
2018 Q3	$50K	Hold	1,000	–	–	﹤0.01%	1324
2018 Q2	$50K	Hold	1,000	–	–	﹤0.01%	1317
2018 Q1	$49K	Hold	1,000	–	–	﹤0.01%	1298
2017 Q4	$44K	Hold	1,000	–	–	﹤0.01%	1344
2017 Q3	$51K	Hold	1,000	–	–	﹤0.01%	1340
2017 Q2	$54K	Hold	1,000	–	–	﹤0.01%	1321
2017 Q1	$53K	Sell	1,000 -280	-22%	-$14.2K	﹤0.01%	1310
2016 Q4	$62K	Hold	1,280	–	–	﹤0.01%	1190
2016 Q3	$69K	Sell	1,280 -2,144	-63%	-$118K	0.01%	1120
2016 Q2	$185K	Buy	3,424 +2,144	+168%	+$113K	0.01%	788
2016 Q1	$65K	Hold	1,280	–	–	﹤0.01%	1048
2015 Q4	$65K	Hold	1,280	–	–	0.01%	1033
2015 Q3	$62K	Hold	1,280	–	–	0.01%	1046
2015 Q2	$67K	Hold	1,280	–	–	0.01%	1046
2015 Q1	$74K	Sell	1,280 -80	-6%	-$4.59K	0.01%	685
2014 Q4	$73K	Hold	1,360	–	–	0.01%	691
2014 Q3	$78K	Sell	1,360 -116	-8%	-$7.11K	0.01%	682
2014 Q2	$99K	Sell	1,476 -3,845	-72%	-$260K	0.01%	665
2014 Q1	$355K	Hold	5,321	–	–	0.03%	405
2013 Q4	$355K	Hold	5,321	–	–	0.03%	284
2013 Q3	$334K	Hold	5,321	–	–	0.04%	208
2013 Q2	$332K	Buy	+5,321	New	+$338K	0.04%	204

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

LS Investment Advisors's GSK Position: Q4 2018 in Review

LS Investment Advisors sold out of GSK (GSK) in Q4 2018, closing a stake of 1,000 shares — an estimated $50K sold.

LS Investment Advisors first reported a position in GSK in Q2 2013 and held it in 22 quarters. The position peaked at $355K in Q1 2014. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

LS Investment Advisors reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
LS Investment Advisors sold 1,000 GSK shares in Q4 2018, an estimated $50K.
LS Investment Advisors first reported a position in GSK in Q2 2013 and held it in 22 quarters.
LS Investment Advisors's GSK position peaked at $355K in Q1 2014.
799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on LS Investment Advisors's 13F filing for Q4 2018, filed 1 Feb 2019.